Sort
39,280 grants matching “leukemia”
Commercializing Praedicare Dx TM platform for guiding cancer treatments
$998,807Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2017 · CA
Illinois Oncology Research Association Community Clinical Oncology Program
$998,654John W Kugler · Oncology-Hematology Assoc-Central Ill · U10 · FY2009 · CA
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$998,324Irving Lerner Weissman · Stanford University · R35 · FY2022 · CA
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$997,850Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations
$997,800William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2023 · CA
The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations
$997,800William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2025 · CA
MOLECULAR TAXONOMY OF PEDIATRIC AND ADULT ACUTE LEUKEMIA
$997,735University Of New Mexico · U01 · FY2004 · CA
SBIR TOPIC 255
$997,607John Fidler · Myelorx, Llc · N43 · FY2010 · CA
Rapidly boosting innate immunity in the lungs to protect against pneumonia
$997,525Brenton Scott · Pulmotect, Inc · R44 · FY2013 · AI
Hematopoiesis from Normal and Patient-Derived Induced Pluripotent Stem Cells
$997,217Mitchell J Weiss · Children'S Hosp Of Philadelphia · RC2 · FY2009 · HL
Modeling HIV CAR-T cell trafficking and persistence in Non-Human Primates
$996,038Hans-Peter Kiem · University Of Pennsylvania · U19 · FY2020 · AI
DEVELOPMENTAL FUNDS (Core 002)
$996,007Michael A Caligiuri · Ohio State University · P30 · FY2017 · CA
Clinical Research Core
$995,835Michael Keating · University Of California, San Diego · P01 · FY2009 · CA
A Novel Compound for Targeted Treatment of CBF Leukemia
$995,100Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Cancer and Leukemia Group B-Leukemia Correlative Science
$994,868Michael A Caligiuri · Ohio State University · U10 · FY2007 · CA
Leadership, Planning and Evaluation
$994,847Caryn Lerman · University Of Southern California · P30 · FY2023 · CA
Comparative Genomics: Mechanism(s) Against Emerging Infectious Diseases
$994,571Stephen J O'Brien · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
STING Activators as Therapy for Cancer
$993,879Glen N Barber · Stinginn, Llc · R42 · FY2023 · CA
Molecular pathogenesis and therapy innovation for Merkel cell carcinoma
$993,703Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR
STING Activators as Therapy for Cancer
$993,220Glen N Barber · Stinginn, Llc · R42 · FY2022 · CA
Non-Clinical Pharmacology of CX-01
$992,960Galina Vid · Ceramedix Holding, Llc · R44 · FY2025 · AI
Matched and Haploidentical transplantation for Adults with Sickle Cell Anemia
$992,903Neal Flomenberg · Thomas Jefferson University · RC2 · FY2009 · HL
Oncogenic NOTCH Signaling
$992,864Jon C Aster · Brigham And Women'S Hospital · P01 · FY2006 · CA
Measureable Residual Disease testing for acute myeloid leukemia with single-cell genotyping
$992,321David W Ruff · Mission Bio, Inc. · R44 · FY2020 · CA
NHGRI/DIR Genomics Core
$992,319Settara Chandrasekharappa · National Human Genome Research Institute · ZIC · FY2018 · HG